Abstract:BACKGROUND: The alteration of endogenous opioid peptide system is one of the important mechanisms for opioid dependence, μ opioid receptor antagonist or activator can regulate opioid receptor in vitro, but the results from the animal experiment vary greatly.OBJECTIVE: To study the locahzation and quantitative changes of μ-opioid receptor in the brain tissues of morphine-dependent and abstinent rats.DESIGN: A completely randomized controlled experimental study.SETTING and MATERIALS: The experiment was conducted in the Depurtment of Anaesthesiology, Changzheng Hospital, Second Military Medical University using 30 male SD rats provided by the Experimental Animal Center, Second Military Medical University.INTERVENTIONS: Thirty SD rats were divided randomly into 3 groups( n =10) . Intraperitoneal injection with morphine was given to the rats in morphine-dependent group and abstinent group to produce morphine - dependent models, and 3 hours after the model establishment, the rats in the abstinent group were injected with naloxone(5 mg/kg) to induce the withdrawal syndromes. The rats in the control group received only injection with saline. All rats were sacrificed by decapitation 24 hours after the last injection of morphine, and the coronal sections of discrete brain regions(namely the frontal cortex, hippocampus, striatum, thalamus, and hypothalamus) were prepared.MAIN OUTCOME MEASURES: The localization and density of μ-opioid receptor in the specified brain regions of rats in all the 3 groups were measured by autoradiography.RESULTS: In morphine dependent group, the density ofμ-opioid receptor in the frontal cortex, hippocampus, striatum, thalamus, and hypothalamus were significantly lowered by 22%, 49%, 21% and 28%, respectively( t = 11.54,17.82, 15.80, 8.35, 13.78, respectively, P ＜ 0. 01) in comparison with the control group. In morphine abstinent group, the densities of μ opioid receptor in those brain regions were significantly higher by 10%, 38%, 12%, 13%, and 58% respectively(t =3.72, 7.77, 5.84, 3.06, 11.24, respectively, P ＜0.01 ) than those in dependent group, but remained lower in then frontal cortex, hippocampus, striatum, thalamus that those in the control group( t = 6. 76,11.73, 10. 19, 5.46, respectively, P ＜ 0.01 ) with the exception of that in the hypothalamus( t = 1.64, P ＞ 0.05).CONCLUSION: Morphine dependence can lower the level of μ-opioid receptor in rat brain, which is difficult to correct through short-term morphine abstinence by naloxone and can be one of the neurobiological mechanisms of opioid dependence and abstinence.

The differential effects of OX1R and OX2R selective antagonists on morphine conditioned place preference in naïve versus morphine-dependent mice

The role of orexin receptors within the CA1 area in the acquisition and expression of methamphetamine place preference

Blocking Alpha(4)Beta(2) And Alpha(7) Nicotinic Acetylcholine Receptors Inhibits The Reinstatement Of Morphine-Induced Cpp By Drug Priming In Mice

Orexin A-mediated AKT signaling in the dentate gyrus contributes to the acquisition, expression and reinstatement of morphine-induced conditioned place preference.

The role of NR2B containing NMDA receptor in place preference conditioned with morphine and natural reinforcers in rats.

Inhibition of Phosphodiesterase10a Attenuates Morphine-Induced Conditioned Place Preference.

Effects of morphine on conditioned place preference and pain are independent of uptake‐2

Blockade of orexin receptor 1 attenuates morphine protracted abstinence-induced anxiety-like behaviors in male mice

Dose- and Time-Dependent, Context-Induced Elevation of Dopamine and Its Metabolites in the Nucleus Accumbens of Morphine-Induced CPP Rats

Blockade of Cannabinoid CB1 Receptor Attenuates the Acquisition of Morphine-Induced Conditioned Place Preference along with a Downregulation of ERK, CREB Phosphorylation, and BDNF Expression in the Nucleus Accumbens and Hippocampus.

Brain opioid-receptors are involved in mediating peripheral electric stimulation-induced inhibition of morphine conditioned place preference in rats

Morphine Differentially Alters the Synaptic and Intrinsic Properties of D1R- and D2R-Expressing Medium Spiny Neurons in the Nucleus Accumbens

Upregulation of HCN2 in ventral tegmental area is involved in morphine‐induced conditioned place preference in rats

Regulation of clock and clock-controlled genes during morphine reward and reinforcement: Involvement of the period 2 circadian clock

Reactivation of Morphine Conditioned Place Preference by Drug Priming: Role of Environmental Cues and Sensitization

Cannabinoid 1 Receptor Blockade in the Dorsal Hippocampus Prevents the Reinstatement but Not Acquisition of Morphine-Induced Conditioned Place Preference in Rats

EFFECTS OF CAFFEINE ON THE ACQUISITION AND REINSTATEMENT OF MORPHINE CONDITIONED PLACE PREFERENCE IN RATS

The α 1 adrenoceptor antagonist prazosin potentiates morphine induced conditioned place preference in rats

Changes of μ-opioid receptor in the brain tissues of morphine-dependent and abstinent rats

Opioid-environment interaction: Contrasting effects of morphine administered in a novel versus familiar environment on acute and repeated morphine induced behavioral effects and on acute morphine ERK activation in reward associated brain areas

Neuropeptide S inhibits the acquisition and the expression of conditioned place preference to morphine in mice.